The Big 3 drug wholesalers in the U.S.--AmerisourceBergen, McKesson and Cardinal Health--are enjoying a financial boost this year thanks to the growing use of generic drugs. That's a bus they hope to ride into 2011 and beyond, when they can expect drug distribution's next big business-shaker: healthcare reform.
Among the Big 3, ASB boasted an 11 percent stock rise at the end of July, compared with three percent rises for McKesson and Cardinal Health, according to Reuters. On the Fortune 500 list, McKesson holds the 14th spot, Cardinal pulls in at 17th, and ASB garners the 24th spot. Click here to begin the report >>